Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash

Journal of Oral Pathology and Medicine

Volumn 30, Issue 8, 2001, Pages 471-480

  Nicolatou Galitis, Ourania ^a   Dardoufas, Konstantinos ^b   Markoulatos, Panagiotis ^c   Sotiropoulou Lontou, Anastasia ^d   Kyprianou, Konstantinos ^e   Kolitsi, Georgia ^e   Pissakas, George ^d   Skarleas, Christos ^b   Kouloulias, Vassilis ^b   Papanicolaou, Vassilis ^f   Legakis, Nicolaos J ^g   Velegraki, Aristea ^g  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c HELLENIC PASTEUR INSTITUTE   (Greece)

^d O Aghios Savas Hospital   (Greece)

^e HYGEIA HOSPITAL   (Greece)

^f Kalamata General Hospital   (Greece)

^g UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Granulocyte macrophage colony stimulating factor (GM CSF); Herpes simplex virus 1 (HSV 1); Oral candidiasis; Oral mucositis; Radiotherapy

Indexed keywords

CANDIDA ALBICANS; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERPES SIMPLEX VIRUS; MUCOSA INFLAMMATION; ORAL PSEUDOMEMBRANOUS CANDIDIASIS; POLYMERASE CHAIN REACTION; VIRUS CULTURE; VIRUS INFECTION;

EID: 0034872142     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2001.030008471.x     Document Type: Article

References (31)

1. Effect of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients
2. A pilot study of the clinical effects of irradiation on the oral tissues
3. Scoring irradiation mucositis in head and neck cancer patients
4. Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts
5. Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer
6. Local control of T3 carcinomas after accelerated fractionation: A look at the "gap"
7. Granulocyte macrophage-colony-stimulating factor mouthwashes heal oral ulcers during head and neck radiotherapy
8. A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: A preliminary report
9. Oral administration of recombinant human granulocyte macrophage colony-stimulating factor in the management of radiotherapy-induced esophagitis
10. Treatment of irradiation-induced mucositis with growth factors (rhGM-CSF) in patients with head and neck cancer
11. Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: A prospective randomized study
12. Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans
13. The effect of granulocyte-macrophage colony-stimulating factor (rGM-CSF) on macrophage function in microbial disease
14. Mouth care for nasopharyngeal cancer patients undergoing radiotherapy
15. Influence of radiation therapy on oral Candida albicans colonization: A quantitative assessment
16. Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck
17. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy
18. Fluconazole prophylaxis in patients with head and neck tumours undergoing radiation and radiochemotherapy
19. Oral herpes simplex virus infection in patients receiving head and neck radiation
20. Reactivation of oral herpes simplex virus. Implications for clinical management of herpes simplex virus recurrence during radiotherapy
21. Yeast flora of the mouth and skin during and after irradiation for oral and laryngeal cancer
22. Variable antifungal susceptibility of wild-type Candida albicans phenotypes from neutropenic hosts
23. Clear detection and typing of herpes simplex virus types 1 and 2 by an indirect ELISA assay: Comparison with three different combined methods - Capture ELI-SA, restriction enzymes, and polymerase chain reaction
24. Detection and typing of HSV-1, HSV-2 and VZV by a multiplex polymerase chain reaction
25. Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole
26. The oral cavity as a port of entry for early infections in patients treated with bone marrow transplantation
27. Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: Analysis of factors associated with infection
28. Studies of the natural history of herpes simplex infections
29. Herpes simplex virus in ocular, nasal, and oral secretions of patients with herpetic keratitis
30. Pathogenesis of herpes simplex labialis: Excretion of virus in the oral cavity